To explore the effect of tirofiban combined with sodium nitroprusside in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).
The clinical data of 97 patients with AMI who underwent PCI in our hospital from June 2019 to June 2022 were retrospectively analyzed, and the patients were divided into tirofiban group (n=48, tirofiban) and combination group (n=49, tirofiban combined with sodium nitroprusside) according to different medication regiments during PCI. Immediate postoperative blood flow improvement, ST segment regression at 2 h after surgery, serum cardiac troponin (cTn) I level before and after surgery, indexes of cardiac function before and after surgery [left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF)] and the incidence of major adverse cardiac event (MACE) within 3 months after surgery were compared between the two groups.
The blood flow improvement rate and ST segment regression rate in the combination group were 97.96% and 95.92%, respectively, which were obviously higher than those in the tirofiban group (87.50% and 83.33%)(P<0.05). On the 3rd day after operation, the level of serum cTnI in the two groups were lower than those before operation (P<0.05), and the combination group was obviously lower than the tirofiban group (P<0.05). One month after operation, the LVEDD in both groups were lower than those before operation (P<0.05), and the LVEF were higher than those before operation (P<0.05), and the above cardiac function indexes in the combination group were obviously better than those in the tirofiban group (P<0.05). The incidence of MACE in the combination group was obviously lower (4.08%) than that in the tirofiban group (18.75%)(P<0.05).
Combined application of tirofiban and sodium nitroprusside during PCI in patients with AMI can effectively promote ST segment regression and coronary blood flow recovery, obviously improve cardiac function, and significantly reduce serum cTnI level and the risk of MACE.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |